Status:
UNKNOWN
The DETECT Project
Lead Sponsor:
Nantes University Hospital
Collaborating Sponsors:
French-Speaking Vascular and Endovascular Surgery Society Support
Boston Scientific Corporation
Conditions:
Femoropopliteal Atheromatous Lesions
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to assess the all-cause mortality at 2 years of patients treated by a paclitaxel drug-eluting devices or non-drug-eluting devices after an endovascular femoropopliteal artery revascula...
Detailed Description
Endovascular intervention is considered as a first-line treatment for femoropopliteal atheromatous lesions. During the 2000s, the superiority of auto-expandable stent compared to percutaneous translum...
Eligibility Criteria
Inclusion
- age ≥ 18 years old on day of hospital admission for the hereafter related surgical procedure
- Affiliated member to the French Social Security system
- Admitted in a French hospital, public or private, between October 2011 and December 2019
- Benefitting from an endovascular femoropopliteal surgical procedure coded with ≥ 1 of the 9 codes of the Common Classification of Medical Procedures (EEAF001, EEAF002, EEAF003, EEAF004, EEAF005, EEAF006, EEPF001, EEPF002, EELF002)
- Associated to the reimbursement by the health insurance scheme for one device of interest cited in the SAP (statistical analyses plan)
Exclusion
- \-
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
250000 Patients enrolled
Trial Details
Trial ID
NCT05254106
Start Date
November 1 2011
End Date
December 31 2024
Last Update
April 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
France
Whole Country, France